UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045301
Receipt number R000051340
Scientific Title Effects of functional food ingestion on glucose metabolism and intestinal microbiota
Date of disclosure of the study information 2021/08/31
Last modified on 2024/03/09 10:29:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of functional food ingestion on glucose metabolism and intestinal microbiota

Acronym

Effects of functional food ingestion on glucose metabolism and intestinal microbiota

Scientific Title

Effects of functional food ingestion on glucose metabolism and intestinal microbiota

Scientific Title:Acronym

Effects of functional food ingestion on glucose metabolism and intestinal microbiota

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the present study is to examine the effects of timing of functional food intake on glucose metabolism and the intestinal microbiota.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The concentrations of blood glucose

Key secondary outcomes

The concentrations of insulin, GLP-1, GIP-1


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Acute ingestion of functional food (Morning trial)

Interventions/Control_2

Acute ingestion of functional food (evening trial)

Interventions/Control_3

Acute ingestion of placebo beverage (Morning trial)

Interventions/Control_4

Acute ingestion of placebo beverage (Evening trial)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

20 yeras-old <=, 80 yeras-old >
Obtained written informed consent from the participant before participation.

Key exclusion criteria

1)individuals who are diagnosed with diabetes or dyslipidaemia, 2)taking any antioxidant, anti-obesity, or antidiabetes medication and supplements, 3)individuals who are using depression, sleeping, steroid medications, 4)individuals who are obese (BMI>35kg/m2), or who suffered from sleep apnea, 5)smoker, 6)individuals who are set pacemaker and metal in body (excluding dental filling), 7)individuals who are engaged shift work and travel with jetlag within 2 weeks.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Takahashi

Organization

Tokyo Institute of Technology

Division name

Institute for Liberal Arts

Zip code

152-8550

Address

2-12-1, Ookayama Meguro-ku, Tokyo, 152-8550

TEL

03-5734-2904

Email

takahashi.m.bp@m.titech.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Takahashi

Organization

Tokyo Institute of Technology

Division name

Institute for Liberal Arts

Zip code

152-8550

Address

2-12-1, Ookayama Meguro-ku, Tokyo, 152-8550

TEL

03-5734-2904

Homepage URL


Email

takahashi.m.bp@m.titech.ac.jp


Sponsor or person

Institute

Tokyo Institute of Technology

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Waseda University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Institute of Technology

Address

2-12-1, Ookayama Meguro-ku, Tokyo

Tel

03-5734-3808

Email

hitorinri@jim.titech.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 31 Day


Related information

URL releasing protocol

https://www.nature.com/articles/s41430-023-01259-x

Publication of results

Partially published


Result

URL related to results and publications

https://www.nature.com/articles/s41430-023-01259-x

Number of participants that the trial has enrolled

12

Results

The incremental area under the blood glucose curve (iAUC) in the EM trials was significantly lower than that in the EP trials. The postprandial glucose concentrations 120 min after the meal were significantly lower in the EM trials than those in the EP trials.

Results date posted

2024 Year 03 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

(1) diagnosed with diabetes or dyslipidaemia; (2) taking any antioxidant, anti-obesity, or antidiabetic medication or supplements; (3) taking depression, sleeping, or steroid medications; (4) obese (body mass index [BMI] > 35 kg/m2) or suffering from sleep apnoea; (5) smoker; (6) set pacemaker or metal in the body (excluding dental fillings); and (7) engaged in shift-work or travel with jetlag within the previous 2 weeks.

Participant flow

Open recruitment

Adverse events

None

Outcome measures

Glucose, insulin, GIP, GLP-1, TG, FFA

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 03 Month 04 Day

Date of IRB

2021 Year 03 Month 04 Day

Anticipated trial start date

2021 Year 03 Month 04 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 30 Day

Last modified on

2024 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051340